US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PepGen Inc.

1.44

-0.0100-0.69%

Volume:129.94K

Turnover:187.58K

Market Cap:47.12M

PE:-0.46

High:1.45

Open:1.45

Low:1.44

Close:1.45

Loading ...

Overview Company News Filings

BUZZ-U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealth

PepGen to Pause Study in Duchenne Muscular Dystrophy; Shares Down Pre-Bell

MT Newswires Live

BUZZ-PepGen slumps after pausing mid-stage study of Duchenne drug

BRIEF-Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD

PepGen to pause CONNECT2-EDO51 study

PepGen to Participate in Upcoming Investor Conferences

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD

Promising Prospects for PepGen Inc.: Buy Rating Affirmed Amid Positive DM1 Treatment Developments

PepGen Inc. Reports Positive Trial Results and Financials

Sell Rating on PepGen Inc. Amid Clinical and Regulatory Challenges

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live

Top Midday Gainers

MT Newswires Live

PepGen Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

PepGen data ‘very encouraging’ for program, says H.C. Wainwright

PepGen initial DM1 data ‘a clear win,’ says Stifel

PepGen Inc. Announces Positive FREEDOM-DM1 Trial Results

BRIEF-PepGen Q4 Operating Expenses USD 24.345 Million

Press Release: PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights

PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1

Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (OtherPMCUF), PepGen Inc. (PEPG) and Idexx Laboratories (IDXX)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PEPG/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PEPG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PEPG\",,,,,undefined,":{"symbol":"PEPG","market":"US","secType":"STK","nameCN":"PepGen Inc.","latestPrice":1.44,"timestamp":1753730611950,"preClose":1.45,"halted":0,"volume":129940,"delay":0,"floatShares":12870445,"shares":32720943,"eps":-3.135021,"marketStatus":"Trading","change":-0.01,"latestTime":"07-28 15:23:46 EDT","open":1.45,"high":1.45,"low":1.435,"amount":187577.732686,"amplitude":0.010345,"askPrice":1.45,"askSize":373,"bidPrice":1.44,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-3.135021,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1753732800000},"marketStatusCode":2,"adr":0,"listingDate":1651809600000,"exchange":"NASDAQ","adjPreClose":1.45,"preHourTrading":{"tag":"盘前","latestPrice":1.44,"preClose":1.45,"latestTime":"08:46 EDT","volume":1246,"amount":1797.4530602000002,"timestamp":1753706760780},"postHourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.45,"latestTime":"19:29 EDT","volume":2196,"amount":3191.14,"timestamp":1753486172489},"volumeRatio":0.782377,"impliedVol":1.3746,"impliedVolPercentile":0.6548},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PEPG\",,,,,undefined,":{"symbol":"PEPG","floatShares":12870445,"roa":"-40.84%","roe":"-75.45%","lyrEps":-2.849026,"volumeRatio":0.782377,"shares":32720943,"dividePrice":0,"high":1.45,"amplitude":0.010345,"preClose":1.45,"low":1.435,"week52Low":0.8801,"pbRate":"0.51","week52High":19.298,"institutionHeld":0,"latestPrice":1.44,"committee":-0.898219,"eps":-3.135021,"divideRate":0,"volume":129940,"delay":0,"ttmEps":-3.135021,"open":1.45,"prevYearClose":3.79,"prevWeekClose":1.45,"prevMonthClose":1.11,"prevQuarterClose":1.11,"fiveDayClose":1.32,"twentyDayClose":1.15,"sixtyDayClose":1.57},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PEPG\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517600360","title":"BUZZ-U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealth","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600360","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517600360?lang=en_us&edition=fundamental","pubTime":"2025-03-05 02:46","pubTimestamp":1741114004,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealthEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3N3PN1GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIW.SI","ENPH","NVDU","AAL","2NVD.UK","EQT","DSP","NEXT","YMAB","WVE","3NVD.UK","ATEC","PEP","UNH","JBLU","NVDS","ULCC","CNX","NVDD","WGRX","TNYA","PEPG","HUT","WBA","ILMN","FITB","MDLZ","SLRN","AMLX","SNVD.UK","UAL","CAPR","OKTA","STIM","EVGO","AGH","NVDY"],"gpt_icon":1},{"id":"2516639674","title":"PepGen to Pause Study in Duchenne Muscular Dystrophy; Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2516639674","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516639674?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:09","pubTimestamp":1741097381,"startTime":"0","endTime":"0","summary":"PepGen  said Tuesday it has made a voluntary decision to temporarily  pause its CONNECT2-EDO51 phase 2 study of PGN-EDO51 in Duchenne muscular dystrophy patients until it can review results from an ongoing study.Pausing the study until PepGen is able to review results from the 10 mg/kg group in the phase 2 CONNECT1-EDO51 trial \"will allow us to gather additional safety data, assess the impact of this dose of PGN-EDO51 on dystrophin levels, and potentially improve the design of CONNECT2,\" said James McArthur, CEO of PepGen.PepGen shares were down 11% in premarket activity Tuesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2516674856","title":"BUZZ-PepGen slumps after pausing mid-stage study of Duchenne drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2516674856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516674856?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:04","pubTimestamp":1741097051,"startTime":"0","endTime":"0","summary":"BUZZ-PepGen slumps after pausing mid-stage study of Duchenne drug** Shares of Boston-based drug developer PepGen PEPG.O fall 9% to $2.56 premarket** Company says it will temporarily pause mid-stage study of PGN-EDO51 in patients with Duchenne muscular dystrophy  ** Says the study is paused until company can review results from patient group dosed with 10 mg/kg, which is expected during Q3** DMD is a genetic disorder causing progressive muscle weakness and degeneration** Company says no new safety issues related to PGN-EDO51 have been observed since the company's last safety update in January** PEPG has fallen 83% in the last 12 months   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3N3PN1AH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2516867697","title":"BRIEF-Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2516867697","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516867697?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:18","pubTimestamp":1741094308,"startTime":"0","endTime":"0","summary":"BRIEF-Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMDMarch 4 (Reuters) - PepGen Inc PEPG.O:PEPGEN ANNOUNCES UPDATE TO PHASE 2 CONNECT2-EDO51 STUDY IN PATIENTS WITH DMDPEPG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUABCFL9S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2516676863","title":"PepGen to pause CONNECT2-EDO51 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2516676863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516676863?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:05","pubTimestamp":1741093550,"startTime":"0","endTime":"0","summary":"PepGen (PEPG) announced its voluntary decision to temporarily pause the Phase 2 CONNECT2-EDO51 study of PGN-EDO51 in patients with Duchenne muscula...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pepgen-to-pause-connect2-edo51-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pepgen-to-pause-connect2-edo51-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2516767246","title":"PepGen to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516767246","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516767246?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:05","pubTimestamp":1741093500,"startTime":"0","endTime":"0","summary":"BOSTON, March 04, 2025----PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences:. Tuesday, March 11, 2025 at 3:00 p.m. ET, Fireside Chat. PepGen is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Delivery Oligonucleotide  platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates designed to target the root cause of serious diseases.For more information, please vi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pepgen-participate-upcoming-investor-conferences-130500120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2516675717","title":"PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675717","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516675717?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093200,"startTime":"0","endTime":"0","summary":"Company will temporarily pause CONNECT2 and focus efforts on ongoing CONNECT1-EDO51 study of PGN-EDO51 in DMD, with 10 mg/kg results expected in the third quarter of 2025. BOSTON, March 04, 2025----PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced its voluntary decision to temporarily pause the Phase 2 CONNECT2-EDO51 study of PGN-EDO51 in patients with Duchenne muscular dystrophy  until the Company can review results from the 10 mg/kg cohort in the ongoing Phase 2 CONNECT1-EDO51 study. The first two cohorts of the CONNECT1 study are fully enrolled and data from the 10 mg/kg cohort are expected during the third quarter of 2025. No new safety issues related to PGN-EDO51 have been observed since the Company’s last safety update as of January 23, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pepgen-announces-phase-2-connect2-130000562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2514876585","title":"Promising Prospects for PepGen Inc.: Buy Rating Affirmed Amid Positive DM1 Treatment Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2514876585","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514876585?lang=en_us&edition=fundamental","pubTime":"2025-02-27 17:35","pubTimestamp":1740648950,"startTime":"0","endTime":"0","summary":"PepGen Inc. (PEPG – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on February 24. Analyst Joseph Schwartz...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-prospects-for-pepgen-inc-buy-rating-affirmed-amid-positive-dm1-treatment-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-prospects-for-pepgen-inc-buy-rating-affirmed-amid-positive-dm1-treatment-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG"],"gpt_icon":0},{"id":"2514074377","title":"PepGen Inc. Reports Positive Trial Results and Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2514074377","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514074377?lang=en_us&edition=fundamental","pubTime":"2025-02-26 12:24","pubTimestamp":1740543866,"startTime":"0","endTime":"0","summary":"PepGen Inc. ( ($PEPG) ) has released its Q4 earnings. Here is a breakdown of the information PepGen Inc. presented to its investors. PepGen Inc. is...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pepgen-inc-reports-positive-trial-results-and-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pepgen-inc-reports-positive-trial-results-and-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2514043066","title":"Sell Rating on PepGen Inc. Amid Clinical and Regulatory Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514043066?lang=en_us&edition=fundamental","pubTime":"2025-02-25 17:55","pubTimestamp":1740477319,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Tazeen Ahmad reiterated a Sell rating on PepGen Inc. (PEPG – Research Report) yesterday and set a price target o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sell-rating-on-pepgen-inc-amid-clinical-and-regulatory-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sell-rating-on-pepgen-inc-amid-clinical-and-regulatory-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG"],"gpt_icon":0},{"id":"2514705385","title":"Sector Update: Health Care Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705385","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514705385?lang=en_us&edition=fundamental","pubTime":"2025-02-25 04:51","pubTimestamp":1740430269,"startTime":"0","endTime":"0","summary":"Health care stocks gained late Monday afternoon with the NYSE Health Care Index climbing 1.1% and the Health Care Select Sector SPDR Fund  rising 0.9%.The iShares Biotechnology ETF  was up 0.1%.In corporate news, Amneal Pharmaceuticals  shares jumped 7% after JPMorgan upgraded the stock to overweight from neutral and raised its price target to $12 from $9.PepGen  shares surged 66% after it reported initial positive data from a phase 1 trial investigating PGN-EDODM1 in myotonic dystrophy type 1.Amgen  will invest an initial $200 million this year in its new technology center in southern India, Reuters reported, citing Chief Executive Robert Bradway. Amgen confirmed the plans in a statement sent to MT Newswires, saying that the investment would back the acceleration of its digital capabilities through AI and data science. Amgen shares rose 2%.Invivyd  dropped 31% after the firm said the US Food and Drug Administration rejected its request to expand the existing emergency use authorizatio","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMGN","LU0868494617.USD","BK4585","IE00B2B36J28.USD","IVVD","IE00B4R5TH58.HKD","LU1061106388.HKD","SG9999001440.SGD","LU0289739699.SGD","LU1983299246.USD","BK4533","BK4534","BK4599","IE00BJT1NW94.SGD","IE0002141913.USD","XLV","LU1571399168.USD","LU0058720904.USD","BK4139","BK4581","IBB","LU2112291526.USD","LU0109394709.USD","LU0122379950.USD","LU0320765992.SGD","LU2242646821.SGD","AMRX","LU1057294990.SGD","LU2242652126.USD","PEPG","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE0009355771.USD","LU1023059063.AUD","BK4588","BK4007","IE00BFTCPJ56.SGD","BK4566"],"gpt_icon":0},{"id":"2514777879","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2514777879","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514777879?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:51","pubTimestamp":1740423063,"startTime":"0","endTime":"0","summary":"PepGen  reported initial positive clinical data from the phase 1 trial investigating PGN-EDODM1 in myotonic dystrophy type 1.The stock surged 82% as intraday trading topped 103.2.9 million shares versus the daily average of 320,000.Connexa Sports Technologies  said its Yuanyu Enterprise Management unit agreed to a multichannel network agency services deal with TikTok to create and sell content for the social media platform's users in the Middle East and North Africa.The shares almost doubled as volume topped 127.5 million versus the daily average of 856,000.Jefferies upgraded Nike  to buy from hold and boosted its price target to $115 from $75.Nike shares jumped 5.1% as volume topped 15 million versus the daily average of 13 million.Price: 2.60, Change: +1.13, Percent Change: +82.44","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","PEPG","LU0823411888.USD","BK4534","BK4146","BK4566","BK4190","BK4561","LU0786609619.USD","LU1303367103.USD","BK4581","BK4139","BK4588","LU2098885051.SGD","BK4558","YYAI","BK4533"],"gpt_icon":1},{"id":"2514774780","title":"PepGen Price Target Maintained With a $16.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2514774780","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514774780?lang=en_us&edition=fundamental","pubTime":"2025-02-25 01:44","pubTimestamp":1740419040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PEPG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2025 12:44 ET (17:44 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG"],"gpt_icon":0},{"id":"2514799507","title":"PepGen data ‘very encouraging’ for program, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2514799507","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514799507?lang=en_us&edition=fundamental","pubTime":"2025-02-25 00:45","pubTimestamp":1740415555,"startTime":"0","endTime":"0","summary":"PepGen (PEPG) announced initial data from the FREEDOM-DM1 trial highlighting a dose- dependent robust increase in the splicing correction at 28 day...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pepgen-data-very-encouraging-for-program-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pepgen-data-very-encouraging-for-program-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2513721505","title":"PepGen initial DM1 data ‘a clear win,’ says Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2513721505","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513721505?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:35","pubTimestamp":1740404113,"startTime":"0","endTime":"0","summary":"After PepGen (PEPG) announced initial clinical data from the five and ten mg/kg dose cohorts in the ongoing FREEDOM-DM1 Phase 1 trial investigating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pepgen-initial-dm1-data-a-clear-win-says-stifel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pepgen-initial-dm1-data-a-clear-win-says-stifel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG","BK4127","SF","BK4139"],"gpt_icon":0},{"id":"2513726524","title":"PepGen Inc. Announces Positive FREEDOM-DM1 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726524","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513726524?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:03","pubTimestamp":1740402237,"startTime":"0","endTime":"0","summary":"The latest update is out from PepGen Inc. ( ($PEPG) ). On February 24, 2025, PepGen Inc. announced positive initial results from its ongoing FREEDO...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pepgen-inc-announces-positive-freedom-dm1-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pepgen-inc-announces-positive-freedom-dm1-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2513723412","title":"BRIEF-PepGen Q4 Operating Expenses USD 24.345 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723412","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513723412?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:30","pubTimestamp":1740400245,"startTime":"0","endTime":"0","summary":"BRIEF-PepGen Q4 Operating Expenses USD 24.345 Million\n\n\nFeb 24 (Reuters) - PepGen Q4 operating income USD -24.345 million.\n\nQ4 net income USD -22.242 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nPLXB94D27:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG"],"gpt_icon":0},{"id":"2513726849","title":"Press Release: PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726849","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513726849?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:30","pubTimestamp":1740400200,"startTime":"0","endTime":"0","summary":"-- The Company today reported positive initial results from the ongoing FREEDOM-DM1 trial in patients with DM1; mean splicing correction of 12.3% and 29.1% in 5 and 10 mg/kg cohorts, respectively --. -- FREEDOM-DM1 15 mg/kg cohort is dosing, with results expected in second half of 2025 --. -- CONNECT1-EDO51 10 mg/kg cohort is fully enrolled, with results expected in third quarter of 2025 --. \"Today, we reported initial results from FREEDOM-DM1, which showed robust splicing correction in patients with DM1 following a single dose of PGN-EDODM1. We believe these data contribute to the growing evidence of our novel EDO platform's potential to deliver the drug to the nucleus, the site of action,\" said James McArthur, PhD, President and CEO of PepGen. \"We remain dedicated to our mission of developing life-changing therapeutics for patients with neuromuscular diseases and are committed to demonstrating the ability of our investigational candidates to address the root cause of disease for impr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2513474019","title":"PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1","url":"https://stock-news.laohu8.com/highlight/detail?id=2513474019","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513474019?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"– Significant mean splicing correction of 29.1% following a single dose of PGN-EDODM1 at 10 mg/kg –。BOSTON, February 24, 2025----PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced initial positive clinical data from the 5 and 10 mg/kg dose cohorts in the ongoing FREEDOM-DM1 Phase 1 trial investigating PGN-EDODM1 in myotonic dystrophy type 1 .PGN-EDODM1 was observed to have a favorable emerging safety profile in the 5 and 10 mg/kg cohorts through the data cut-off date of December 3, 2024, which has continued through the date of this release. There were no adverse events related to electrolytes","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pepgen-announces-positive-initial-results-120000624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2508795481","title":"Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (OtherPMCUF), PepGen Inc. (PEPG) and Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2508795481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508795481?lang=en_us&edition=fundamental","pubTime":"2025-02-04 15:00","pubTimestamp":1738652429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pro Medicus Limited (PMCUF – Research Report), PepGe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pro-medicus-limited-otherpmcuf-pepgen-inc-pepg-and-idexx-laboratories-idxx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pro-medicus-limited-otherpmcuf-pepgen-inc-pepg-and-idexx-laboratories-idxx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0690374615.EUR","GB00B4QBRK32.GBP","LU1941712348.USD","PEPG","BK4504","BK4139","LU1291159041.SGD","BK4137","BK4588","LU2404859667.USD","IDXX","GB00B4LPDJ14.GBP","HCSG","LU2404859741.USD","LU1989771016.USD","BK4585","LU1941712264.USD","LU0170899867.USD","BK4082","BK4567","LU0690374961.EUR"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":44,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PEPG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"PEPG","fiscalQuarterEnding":"2025/03","expectedEps":-0.72,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.92},{"market":"US","date":"2025-02-24","symbol":"PEPG","fiscalQuarterEnding":"2024/12","expectedEps":-0.81,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740373200000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-11-07","symbol":"PEPG","fiscalQuarterEnding":"2024/09","expectedEps":-0.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.66},{"market":"US","date":"2024-03-06","symbol":"PEPG","fiscalQuarterEnding":"2023/12","expectedEps":-1.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709701200000,"reportTimeType":"post","actualEps":-0.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PEPG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PEPG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.2,"hold":0,"sell":0.2,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":5,"updateTime":1734408000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PEPG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PEPG","date":"2025-07-25","current":-0.461206,"percent":0.947637,"low":-10.580456,"twenty":-5.89271,"median":-3.541758,"eighty":-1.498253,"high":-0.349107,"avg":-3.767306,"sd":2.353795,"marketCap":47118157},"quantilePoints":[{"date":"2022-05-06","current":-10.580456,"twenty":-10.288242,"median":-9.84992,"eighty":-9.367212,"marketCap":288645421},{"date":"2022-05-13","current":-9.628297,"twenty":-9.817087,"median":-9.763734,"eighty":-9.34265,"marketCap":262669573},{"date":"2022-05-20","current":-9.226092,"twenty":-9.772763,"median":-9.628297,"eighty":-9.232659,"marketCap":251697016},{"date":"2022-05-27","current":-8.930594,"twenty":-9.767838,"median":-9.336904,"eighty":-8.669571,"marketCap":243635546},{"date":"2022-06-03","current":-8.684346,"twenty":-9.766196,"median":-9.205571,"eighty":-8.733596,"marketCap":236917654},{"date":"2022-06-10","current":-9.160426,"twenty":-9.733363,"median":-9.152218,"eighty":-8.728671,"marketCap":249905578},{"date":"2022-06-17","current":-6.915214,"twenty":-9.615164,"median":-9.094708,"eighty":-8.515256,"marketCap":268939605},{"date":"2022-06-24","current":-6.759752,"twenty":-9.562631,"median":-9.000364,"eighty":-7.559814,"marketCap":262893503},{"date":"2022-07-01","current":-5.878796,"twenty":-9.431299,"median":-8.90597,"eighty":-6.828846,"marketCap":228632254},{"date":"2022-07-08","current":-6.892183,"twenty":-9.280267,"median":-8.643305,"eighty":-6.816179,"marketCap":268043886},{"date":"2022-07-15","current":-5.395134,"twenty":-9.229375,"median":-8.544806,"eighty":-6.734417,"marketCap":209822157},{"date":"2022-07-22","current":-6.788541,"twenty":-9.193259,"median":-8.183642,"eighty":-6.38549,"marketCap":264013151},{"date":"2022-07-29","current":-6.448826,"twenty":-9.165351,"median":-7.364369,"eighty":-6.443068,"marketCap":250801297},{"date":"2022-08-05","current":-6.489131,"twenty":-9.15386,"median":-7.047646,"eighty":-6.405066,"marketCap":252368805},{"date":"2022-08-12","current":-4.845367,"twenty":-9.152218,"median":-6.946883,"eighty":-6.325607,"marketCap":246227027},{"date":"2022-08-19","current":-4.706266,"twenty":-9.145651,"median":-6.897941,"eighty":-6.120627,"marketCap":239158309},{"date":"2022-08-26","current":-4.581074,"twenty":-9.065127,"median":-6.854757,"eighty":-5.91104,"marketCap":232796462},{"date":"2022-09-02","current":-4.534707,"twenty":-9.038923,"median":-6.811573,"eighty":-5.653087,"marketCap":230440223},{"date":"2022-09-09","current":-4.590348,"twenty":-8.992977,"median":-6.794299,"eighty":-4.938101,"marketCap":233267710},{"date":"2022-09-16","current":-2.610471,"twenty":-8.943727,"median":-6.719447,"eighty":-4.823111,"marketCap":132656283},{"date":"2022-09-23","current":-2.309084,"twenty":-8.91582,"median":-6.615805,"eighty":-4.590348,"marketCap":117340727},{"date":"2022-09-30","current":-4.210137,"twenty":-8.772996,"median":-6.468979,"eighty":-4.540271,"marketCap":213946546},{"date":"2022-10-07","current":-5.559421,"twenty":-8.659721,"median":-6.420037,"eighty":-4.540271,"marketCap":282513116},{"date":"2022-10-14","current":-5.100387,"twenty":-8.62853,"median":-6.296242,"eighty":-4.566237,"marketCap":259186345},{"date":"2022-10-21","current":-4.349239,"twenty":-8.603905,"median":-6.143658,"eighty":-4.540271,"marketCap":221015265},{"date":"2022-10-28","current":-5.012289,"twenty":-8.534956,"median":-6.077443,"eighty":-4.532853,"marketCap":254709489},{"date":"2022-11-04","current":-4.984469,"twenty":-8.470931,"median":-5.988196,"eighty":-4.540271,"marketCap":253295746},{"date":"2022-11-11","current":-5.134023,"twenty":-8.291991,"median":-5.898949,"eighty":-4.552327,"marketCap":314777227},{"date":"2022-11-18","current":-6.051364,"twenty":-7.809345,"median":-5.878796,"eighty":-4.571801,"marketCap":371021206},{"date":"2022-11-25","current":-5.746868,"twenty":-7.490864,"median":-5.870208,"eighty":-4.584784,"marketCap":352351986},{"date":"2022-12-02","current":-5.758431,"twenty":-7.368983,"median":-5.771921,"eighty":-4.590348,"marketCap":353060944},{"date":"2022-12-09","current":-5.238091,"twenty":-7.334388,"median":-5.758431,"eighty":-4.61075,"marketCap":321157847},{"date":"2022-12-16","current":-5.477062,"twenty":-7.213473,"median":-5.732221,"eighty":-4.667318,"marketCap":335809640},{"date":"2022-12-23","current":-5.789266,"twenty":-7.047646,"median":-5.746868,"eighty":-4.706266,"marketCap":354951498},{"date":"2022-12-30","current":-5.153295,"twenty":-7.031524,"median":-5.693886,"eighty":-4.71183,"marketCap":315958823},{"date":"2023-01-06","current":-5.804684,"twenty":-6.967035,"median":-5.693886,"eighty":-4.734086,"marketCap":355896775},{"date":"2023-01-13","current":-6.166995,"twenty":-6.92673,"median":-5.693397,"eighty":-4.789727,"marketCap":378110784},{"date":"2023-01-20","current":-6.664209,"twenty":-6.917517,"median":-5.707168,"eighty":-4.808273,"marketCap":408595965},{"date":"2023-01-27","current":-6.213247,"twenty":-6.901396,"median":-5.75788,"eighty":-4.816954,"marketCap":380946614},{"date":"2023-02-03","current":-5.928024,"twenty":-6.893335,"median":-5.769995,"eighty":-4.836178,"marketCap":363458991},{"date":"2023-02-10","current":-6.587121,"twenty":-6.88297,"median":-5.781558,"eighty":-4.84444,"marketCap":403869581},{"date":"2023-02-17","current":-6.556286,"twenty":-6.83921,"median":-5.804684,"eighty":-4.849077,"marketCap":401979027},{"date":"2023-02-24","current":-6.47149,"twenty":-6.824881,"median":-5.862986,"eighty":-4.852786,"marketCap":396780003},{"date":"2023-03-03","current":-6.109179,"twenty":-6.819293,"median":-5.878796,"eighty":-4.862987,"marketCap":374565995},{"date":"2023-03-10","current":-5.538732,"twenty":-6.813876,"median":-5.902363,"eighty":-4.871333,"marketCap":339590747},{"date":"2023-03-17","current":-6.822238,"twenty":-6.813876,"median":-5.878796,"eighty":-4.88988,"marketCap":418285054},{"date":"2023-03-24","current":-5.241352,"twenty":-6.804663,"median":-5.882211,"eighty":-4.914918,"marketCap":362198413},{"date":"2023-03-31","current":-4.208913,"twenty":-6.796602,"median":-5.870208,"eighty":-4.852786,"marketCap":290852698},{"date":"2023-04-06","current":-3.957686,"twenty":-6.791996,"median":-5.809194,"eighty":-4.827071,"marketCap":273491907},{"date":"2023-04-14","current":-3.548151,"twenty":-6.78653,"median":-5.796975,"eighty":-4.717394,"marketCap":245191440},{"date":"2023-04-21","current":-4.322481,"twenty":-6.774009,"median":-5.777703,"eighty":-4.590348,"marketCap":298700726},{"date":"2023-04-28","current":-5.062396,"twenty":-6.727508,"median":-5.762285,"eighty":-4.590348,"marketCap":349831822},{"date":"2023-05-05","current":-5.059038,"twenty":-6.673168,"median":-5.746868,"eighty":-4.594705,"marketCap":349599765},{"date":"2023-05-12","current":-5.041307,"twenty":-6.664209,"median":-5.695324,"eighty":-4.617285,"marketCap":338659909},{"date":"2023-05-19","current":-5.292665,"twenty":-6.651757,"median":-5.689053,"eighty":-4.651462,"marketCap":355545340},{"date":"2023-05-26","current":-5.027146,"twenty":-6.627029,"median":-5.6428,"eighty":-4.682483,"marketCap":337708617},{"date":"2023-06-02","current":-5.22186,"twenty":-6.617526,"median":-5.615819,"eighty":-4.706266,"marketCap":350788880},{"date":"2023-06-09","current":-5.80246,"twenty":-6.613923,"median":-5.619674,"eighty":-4.709351,"marketCap":389791847},{"date":"2023-06-16","current":-4.570455,"twenty":-6.602539,"median":-5.600402,"eighty":-4.646407,"marketCap":307029454},{"date":"2023-06-23","current":-3.402174,"twenty":-6.587121,"median":-5.577654,"eighty":-4.590348,"marketCap":228547874},{"date":"2023-06-30","current":-3.455278,"twenty":-6.584038,"median":-5.56064,"eighty":-4.555109,"marketCap":232115218},{"date":"2023-07-07","current":-2.793252,"twenty":-6.569391,"median":-5.550856,"eighty":-4.526361,"marketCap":187642323},{"date":"2023-07-14","current":-2.956104,"twenty":-6.557828,"median":-5.538732,"eighty":-4.44661,"marketCap":198582179},{"date":"2023-07-21","current":-2.821574,"twenty":-6.553974,"median":-5.502116,"eighty":-4.393239,"marketCap":189544907},{"date":"2023-07-28","current":-2.017939,"twenty":-6.547807,"median":-5.477062,"eighty":-4.337232,"marketCap":135559092},{"date":"2023-08-04","current":-2.017939,"twenty":-6.54246,"median":-5.426956,"eighty":-4.319075,"marketCap":135559092},{"date":"2023-08-11","current":-1.819033,"twenty":-6.538589,"median":-5.413033,"eighty":-4.237584,"marketCap":126211799},{"date":"2023-08-18","current":-2.309829,"twenty":-6.537014,"median":-5.39612,"eighty":-4.161181,"marketCap":160265171},{"date":"2023-08-25","current":-1.841342,"twenty":-6.508284,"median":-5.365285,"eighty":-3.959751,"marketCap":127759679},{"date":"2023-09-01","current":-2.162247,"twenty":-6.487797,"median":-5.32819,"eighty":-3.925336,"marketCap":150025346},{"date":"2023-09-08","current":-2.165679,"twenty":-6.480741,"median":-5.297975,"eighty":-3.659632,"marketCap":150263481},{"date":"2023-09-15","current":-2.097036,"twenty":-6.468406,"median":-5.292052,"eighty":-3.522166,"marketCap":145500772},{"date":"2023-09-22","current":-1.887676,"twenty":-6.457799,"median":-5.24042,"eighty":-3.35802,"marketCap":130974508},{"date":"2023-09-29","current":-1.743526,"twenty":-6.448826,"median":-5.22186,"eighty":-3.217961,"marketCap":120972818},{"date":"2023-10-06","current":-1.678316,"twenty":-6.448641,"median":-5.175203,"eighty":-3.007083,"marketCap":116448244},{"date":"2023-10-13","current":-1.935726,"twenty":-6.437033,"median":-5.153295,"eighty":-2.877511,"marketCap":134308405},{"date":"2023-10-20","current":-1.87738,"twenty":-6.41595,"median":-5.138035,"eighty":-2.738733,"marketCap":130260102},{"date":"2023-10-27","current":-1.832762,"twenty":-6.411863,"median":-5.137386,"eighty":-2.672884,"marketCap":127164340},{"date":"2023-11-03","current":-1.760687,"twenty":-6.391319,"median":-5.132844,"eighty":-2.525739,"marketCap":122163496},{"date":"2023-11-10","current":-1.30856,"twenty":-6.383611,"median":-5.099169,"eighty":-2.414802,"marketCap":96921136},{"date":"2023-11-17","current":-1.337497,"twenty":-6.379756,"median":-5.08379,"eighty":-2.30968,"marketCap":99064355},{"date":"2023-11-24","current":-1.440381,"twenty":-6.365109,"median":-5.06793,"eighty":-2.272918,"marketCap":106684690},{"date":"2023-12-01","current":-1.575417,"twenty":-6.353547,"median":-5.060717,"eighty":-2.182362,"marketCap":116686380},{"date":"2023-12-08","current":-2.038396,"twenty":-6.347912,"median":-5.041307,"eighty":-2.155383,"marketCap":150977887},{"date":"2023-12-15","current":-2.279531,"twenty":-6.330776,"median":-5.005334,"eighty":-2.155383,"marketCap":168838048},{"date":"2023-12-22","current":-2.173432,"twenty":-6.314232,"median":-4.961285,"eighty":-2.139706,"marketCap":160979577},{"date":"2023-12-27","current":-2.276316,"twenty":-6.309607,"median":-4.947375,"eighty":-2.145086,"marketCap":168599912},{"date":"2024-01-05","current":-2.517451,"twenty":-6.309607,"median":-4.917622,"eighty":-2.145086,"marketCap":186460073},{"date":"2024-01-12","current":-2.237735,"twenty":-6.293418,"median":-4.901008,"eighty":-2.152448,"marketCap":165742287},{"date":"2024-01-19","current":-2.176647,"twenty":-6.279542,"median":-4.868551,"eighty":-2.149994,"marketCap":161217713},{"date":"2024-01-26","current":-2.228089,"twenty":-6.26387,"median":-4.847686,"eighty":-2.159312,"marketCap":165027880},{"date":"2024-02-02","current":-3.983553,"twenty":-6.236762,"median":-4.817965,"eighty":-2.162863,"marketCap":295049847},{"date":"2024-02-09","current":-6.385761,"twenty":-6.236762,"median":-4.815437,"eighty":-2.164543,"marketCap":472974124},{"date":"2024-02-16","current":-5.971046,"twenty":-6.217872,"median":-4.845367,"eighty":-2.168425,"marketCap":442257448},{"date":"2024-02-23","current":-5.903337,"twenty":-6.211356,"median":-4.854641,"eighty":-2.172721,"marketCap":437242480},{"date":"2024-03-01","current":-7.172872,"twenty":-6.242031,"median":-4.887098,"eighty":-2.174075,"marketCap":531273121},{"date":"2024-03-08","current":-5.652729,"twenty":-6.270849,"median":-4.911053,"eighty":-2.177199,"marketCap":444451496},{"date":"2024-03-15","current":-5.723947,"twenty":-6.25312,"median":-4.95433,"eighty":-2.180142,"marketCap":450051025},{"date":"2024-03-22","current":-6.086065,"twenty":-6.25312,"median":-4.998379,"eighty":-2.183328,"marketCap":478522981},{"date":"2024-03-28","current":-5.798016,"twenty":-6.2473,"median":-5.027146,"eighty":-2.184331,"marketCap":455874834},{"date":"2024-04-05","current":-4.76927,"twenty":-6.220956,"median":-5.034226,"eighty":-2.189508,"marketCap":374988597},{"date":"2024-04-12","current":-5.230148,"twenty":-6.213247,"median":-5.027146,"eighty":-2.189704,"marketCap":411225631},{"date":"2024-04-19","current":-4.879466,"twenty":-6.203794,"median":-5.029888,"eighty":-2.199153,"marketCap":383652857},{"date":"2024-04-26","current":-4.819734,"twenty":-6.166995,"median":-4.998379,"eighty":-2.205583,"marketCap":378956389},{"date":"2024-05-03","current":-5.969241,"twenty":-6.166995,"median":-5.005334,"eighty":-2.208798,"marketCap":469337548},{"date":"2024-05-10","current":-5.495492,"twenty":-6.149416,"median":-5.032629,"eighty":-2.208798,"marketCap":432088536},{"date":"2024-05-17","current":-5.508665,"twenty":-6.148781,"median":-5.053766,"eighty":-2.212013,"marketCap":442494520},{"date":"2024-05-24","current":-5.746768,"twenty":-6.143658,"median":-5.062396,"eighty":-2.217161,"marketCap":461620657},{"date":"2024-05-31","current":-6.598291,"twenty":-6.148908,"median":-5.06793,"eighty":-2.225903,"marketCap":530020909},{"date":"2024-06-07","current":-6.99782,"twenty":-6.205685,"median":-5.084957,"eighty":-2.235806,"marketCap":562113918},{"date":"2024-06-14","current":-7.05432,"twenty":-6.25021,"median":-5.092261,"eighty":-2.239664,"marketCap":566652323},{"date":"2024-06-21","current":-6.779895,"twenty":-6.298815,"median":-5.107245,"eighty":-2.245948,"marketCap":544608640},{"date":"2024-06-28","current":-6.642683,"twenty":-6.31192,"median":-5.123473,"eighty":-2.250945,"marketCap":533586799},{"date":"2024-07-05","current":-6.731467,"twenty":-6.352619,"median":-5.135459,"eighty":-2.255593,"marketCap":540718579},{"date":"2024-07-12","current":-6.981678,"twenty":-6.380527,"median":-5.138193,"eighty":-2.258955,"marketCap":560817231},{"date":"2024-07-15","current":-6.796038,"twenty":-6.383424,"median":-5.139314,"eighty":-2.259598,"marketCap":545905328},{"date":"2024-08-02","current":-4.063901,"twenty":-6.38284,"median":-5.138193,"eighty":-2.260241,"marketCap":326441012},{"date":"2024-08-09","current":-3.2831,"twenty":-6.378985,"median":-5.135459,"eighty":-2.276316,"marketCap":292655523},{"date":"2024-08-16","current":-3.316004,"twenty":-6.360187,"median":-5.114102,"eighty":-2.279531,"marketCap":295588597},{"date":"2024-08-23","current":-3.549989,"twenty":-6.355859,"median":-5.092261,"eighty":-2.279531,"marketCap":316446006},{"date":"2024-08-30","current":-3.381812,"twenty":-6.35354,"median":-5.08379,"eighty":-2.285901,"marketCap":301454743},{"date":"2024-09-06","current":-3.239228,"twenty":-6.352312,"median":-5.06793,"eighty":-2.296807,"marketCap":288744759},{"date":"2024-09-13","current":-3.308692,"twenty":-6.346548,"median":-5.060717,"eighty":-2.307174,"marketCap":294936803},{"date":"2024-09-20","current":-3.418372,"twenty":-6.325973,"median":-5.048713,"eighty":-2.30968,"marketCap":304713713},{"date":"2024-09-27","current":-3.177075,"twenty":-6.31192,"median":-5.029888,"eighty":-2.311389,"marketCap":283204510},{"date":"2024-10-04","current":-3.290412,"twenty":-6.309607,"median":-4.998379,"eighty":-2.327135,"marketCap":293307318},{"date":"2024-10-11","current":-3.162451,"twenty":-6.288022,"median":-4.972877,"eighty":-2.336118,"marketCap":281900922},{"date":"2024-10-18","current":-3.242884,"twenty":-6.276459,"median":-4.924191,"eighty":-2.340714,"marketCap":289070656},{"date":"2024-10-25","current":-3.008899,"twenty":-6.258643,"median":-4.907611,"eighty":-2.384529,"marketCap":268213247},{"date":"2024-10-31","current":-2.584801,"twenty":-6.25021,"median":-4.898921,"eighty":-2.404766,"marketCap":230409193},{"date":"2024-11-08","current":-2.103309,"twenty":-6.231494,"median":-4.879466,"eighty":-2.384804,"marketCap":183480022},{"date":"2024-11-15","current":-1.677727,"twenty":-6.216331,"median":-4.870869,"eighty":-2.323296,"marketCap":146354859},{"date":"2024-11-22","current":-1.614205,"twenty":-6.207575,"median":-4.850004,"eighty":-2.29408,"marketCap":140813583},{"date":"2024-11-29","current":-1.886976,"twenty":-6.189074,"median":-4.840731,"eighty":-2.277602,"marketCap":164608471},{"date":"2024-12-06","current":-2.103698,"twenty":-6.166995,"median":-4.81885,"eighty":-2.254876,"marketCap":183513999},{"date":"2024-12-13","current":-1.928079,"twenty":-6.159963,"median":-4.811645,"eighty":-2.233539,"marketCap":168194002},{"date":"2024-12-20","current":-1.528264,"twenty":-6.149162,"median":-4.753308,"eighty":-2.210084,"marketCap":133316564},{"date":"2024-12-27","current":-1.599259,"twenty":-6.147756,"median":-4.727888,"eighty":-2.200439,"marketCap":139509754},{"date":"2025-01-03","current":-1.408693,"twenty":-6.143658,"median":-4.706266,"eighty":-2.184331,"marketCap":122885928},{"date":"2025-01-10","current":-1.289122,"twenty":-6.143178,"median":-4.693198,"eighty":-2.176004,"marketCap":112455292},{"date":"2025-01-17","current":-0.904254,"twenty":-6.136968,"median":-4.641352,"eighty":-2.163478,"marketCap":78881683},{"date":"2025-01-24","current":-0.728634,"twenty":-6.130009,"median":-4.590348,"eighty":-2.145086,"marketCap":63561687},{"date":"2025-01-31","current":-0.538068,"twenty":-6.121945,"median":-4.575765,"eighty":-2.127223,"marketCap":46937861},{"date":"2025-02-07","current":-0.515649,"twenty":-6.113101,"median":-4.543981,"eighty":-2.103542,"marketCap":44982117},{"date":"2025-02-14","current":-0.452127,"twenty":-6.104554,"median":-4.525434,"eighty":-2.087226,"marketCap":39440841},{"date":"2025-02-21","current":-0.538068,"twenty":-6.09992,"median":-4.492102,"eighty":-2.061071,"marketCap":46937861},{"date":"2025-02-28","current":-0.882881,"twenty":-6.092983,"median":-4.472991,"eighty":-2.017939,"marketCap":79442502},{"date":"2025-03-07","current":-0.879248,"twenty":-6.084519,"median":-4.411834,"eighty":-1.989801,"marketCap":79115578},{"date":"2025-03-14","current":-0.817482,"twenty":-6.072235,"median":-4.394752,"eighty":-1.946683,"marketCap":73557873},{"date":"2025-03-21","current":-0.684868,"twenty":-6.05492,"median":-4.34833,"eighty":-1.929079,"marketCap":61625151},{"date":"2025-03-28","current":-0.584954,"twenty":-6.050431,"median":-4.33982,"eighty":-1.913074,"marketCap":52634744},{"date":"2025-04-04","current":-0.455973,"twenty":-6.048422,"median":-4.324202,"eighty":-1.891794,"marketCap":41028946},{"date":"2025-04-11","current":-0.425091,"twenty":-6.045967,"median":-4.31904,"eighty":-1.87532,"marketCap":38250093},{"date":"2025-04-17","current":-0.44689,"twenty":-6.043655,"median":-4.305274,"eighty":-1.867769,"marketCap":40211637},{"date":"2025-04-25","current":-0.610387,"twenty":-6.03903,"median":-4.222134,"eighty":-1.84839,"marketCap":54923211},{"date":"2025-05-02","current":-0.534088,"twenty":-6.017332,"median":-4.208913,"eighty":-1.830016,"marketCap":48057810},{"date":"2025-05-09","current":-0.493234,"twenty":-6.001276,"median":-4.076181,"eighty":-1.799813,"marketCap":50390252},{"date":"2025-05-16","current":-0.458003,"twenty":-5.986183,"median":-3.983553,"eighty":-1.760687,"marketCap":46790948},{"date":"2025-05-23","current":-0.470814,"twenty":-5.976714,"median":-3.95833,"eighty":-1.751763,"marketCap":48099786},{"date":"2025-05-30","current":-0.53487,"twenty":-5.971046,"median":-3.947361,"eighty":-1.743526,"marketCap":54643974},{"date":"2025-06-06","current":-0.4548,"twenty":-5.969241,"median":-3.923271,"eighty":-1.722933,"marketCap":46463739},{"date":"2025-06-13","current":-0.470814,"twenty":-5.967452,"median":-3.787545,"eighty":-1.6852,"marketCap":48099786},{"date":"2025-06-20","current":-0.470814,"twenty":-5.963661,"median":-3.744949,"eighty":-1.67698,"marketCap":48099786},{"date":"2025-06-27","current":-0.409961,"twenty":-5.959343,"median":-3.601173,"eighty":-1.642704,"marketCap":41882807},{"date":"2025-07-03","current":-0.390744,"twenty":-5.940215,"median":-3.583659,"eighty":-1.607234,"marketCap":39919550},{"date":"2025-07-11","current":-0.400352,"twenty":-5.92267,"median":-3.566648,"eighty":-1.583615,"marketCap":40901178},{"date":"2025-07-18","current":-0.43238,"twenty":-5.909643,"median":-3.557301,"eighty":-1.52378,"marketCap":44173273},{"date":"2025-07-25","current":-0.461206,"twenty":-5.89271,"median":-3.541758,"eighty":-1.498253,"marketCap":47118157}],"updateTime":1753730626845}}}